{"brief_title": "Efficacy and Safety Study of Pegasys in the Treatment of Chronic Hepatitis B", "brief_summary": "The purpose of this study is to determine the safety and efficacy of Pegasys + placebo + lamivudine versus lamivudine alone in patients with lamivudine versus lamivudine alone in patients with hepatitis B antigen CHB.", "condition": ["Chronic Hepatitis B"], "intervention_type": ["Drug"], "intervention_name": ["PEGASYS"], "criteria": "Inclusion Criteria: - Clinical diagnosis of hepatitis B - Not pregnant Exclusion Criteria: - Treatment for hepatitis B in past 6 months - Other hepatitis infections - Severe liver disease - Pregnancy", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Hepatitis", "Hepatitis, Chronic", "Hepatitis B", "Hepatitis B, Chronic", "Peginterferon alfa-2a"], "id": "NCT00048945"}